Health News Releases

  • Today December 19
March 02, 2021 15:05
Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
Boehringer Ingelheim and Gubra today announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the treatment of obes
February 26, 2021 17:25
Journal of Allergy and Infectious Disease Review Confirms Nasal Hygiene Options Are Effective Tools as Part of Multilayered Defense Against COVID-19
A new review published in the highly regarded Journal of Allergy and Infectious Disease finds that nasal hygiene options (such as nasal sprays) are effective tools in combating COVID-19 pandemic—as pa
February 26, 2021 13:45
Saint-Gobain Life Sciences Introduces Highly Efficient Cell Culture Bags for T Cell Expansion
Saint-Gobain Life Sciences, an industry leader in material science-based solutions for cell and gene therapy manufacturing, today launched a new cell culture bag designed specifically for T cell deriv
February 25, 2021 15:20
Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced today that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax’ COVID-19 vaccine candidate (TAK-
February 24, 2021 17:10
Forest Devices Announces Positive Study Results for Their Stroke Detection Technology
Medical technology pioneer Forest Devices, Inc. (FDI) today announced the publication of positive results from the EDGAR study of its AlphaStroke™ technology in identifying patients with large vessel
February 24, 2021 16:00
Yokogawa and ICQ Consultants Enter Into Partnership Agreement for Biopharmaceutical Business
Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification Consultants, Corp. (ICQ Consultants) of Southborough announce that they have entered into a partner
The world’s first ring-type heart-monitoring device, CART-I developed by Sky Labs
February 23, 2021 11:00
Sky Labs Provided CART-I For Clinical Study of Oxford University Professor Betts
Sky Labs, a healthcare start-up, announced that CART-I, its ring-type heart-monitoring device, had been provided for Timothy Betts, professor of medicine at Oxford University, for his clinical researc
February 23, 2021 10:40
LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States
LG Chem Life Sciences (“LG Chem”) today announced the first healthy adult volunteer has been safely dosed in the phase I study of LG00303174 being run in the US. LG Chem licensed LG00303174 (TT-010
Herbalife Nutrition Korea signing sponsorship deal with Korean Diabetes Society
February 22, 2021 17:07
Herbalife Nutrition Korea signs sponsorship deal with Korean Diabetes Society for the sixth consecutive year to continuously support diabetes education and prevention
Herbalife Nutrition Korea, a premier global nutrition company, announced on the 22nd that it signed a sponsorship deal with the Korean Diabetes Society (KDS) for the sixth consecutive year and receive
February 22, 2021 15:40
Laipac Technology Partners With Two UAE Companies to Launch World’s First AI Rapid Antigen Test System
Laipac Technology Inc., of Ontario, Canada, an award-winning leader in the development of IoMT (Internet of Medical Things) is pleased to announce their partnership with UAE companies YAS Pharmaceutic
February 19, 2021 15:25
President of Israel Reuven Rivlin Visits Allscripts Office in Beer Sheva
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) recently hosted Mr. Reuven Rivlin, President of Israel, and the Mayor of Beer Sheva, Mr. Ruvik Danilovich, at its office in Beer Sheva, Israel. The
February 19, 2021 14:30
Final Data From the NuProtect Study Published on the Immunogenicity of Nuwiq® in Previously Untreated Patients With Severe Haemophilia A
Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the
ESMO, the leading organisation for medical oncology, has launched an important new service for rapid
February 18, 2021 10:22
Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-breaking Cancer Research
ESMO, the leading organisation for medical oncology, has launched an important new service for rapidly disseminating research to accelerate the transition of results into practice for the benefit of c
February 17, 2021 18:00
Kaneka Eurogentec Receives GMP Accreditation for New mRNA Manufacturing Facility - COVID-19 Vaccine Production Ongoing
Kaneka Eurogentec: A new GMP facility for active pharmaceutical ingredient production The new facility audited and accredited by Belgian Authorities will allow the production and the purificatio
February 17, 2021 15:56
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
Ferring Pharmaceuticals, Rebiotix Inc., a Ferring Company, and MyBiotics Pharma Ltd. today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address ba
February 15, 2021 17:35
Patient Safety Movement Foundation Announces Winners of 2020 Humanitarian Awards
The Patient Safety Movement Foundation (PSMF), a global non-profit committed to achieving zero preventable patient deaths by 2030, announced the winners of its 2020 Humanitarian Awards at a virtual ce
February 15, 2021 16:16
Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today at the 2021 Transplantation & Cellular Therapy (TCT) Meetings Digital Experience announced new, late-breaking Phase 3 data fr
February 15, 2021 12:39
Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has submitted an application to the Japanese Ministry of Health, Labour and Welfare to manufacture and mark
February 15, 2021 09:47
GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome
GNT Pharma today announced the Korea Animal and Plant Quarantine Agency (APQA) has approved the New Drug Application for GedaCure®, a chewable tablet of crisdesalazine, for the treatment of dogs with
February 10, 2021 18:20
Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has submitted an application to the Japanese Ministry of Health, Labour and Welfare to manufacture and mark
February 10, 2021 17:28
MED™ 3D Printed Pharmaceutical Product Receives IND Clearance From the US FDA
Triastek, Inc. (“Triastek”), a pharmaceutical company specializing in 3D printing of drug products, announced today that the United States Food and Drug Administration (FDA) has approved its Investiga
February 10, 2021 15:30
Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL
Rhizen Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company, today announced that its novel next generation PI3K-delta inhibitor, Umbralisib, which was licensed to TG Therapeut
February 09, 2021 14:30
ImmunoMet Therapeutics Receives IND Clearance and Orphan Drug Designation from U.S. FDA for IM156 in Ideopathic Pulmonary Fibrosis and Completes Financing
ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that the U.S. Food and Drug Administ
February 08, 2021 17:10
Diagnostic Flexibility at Your Fingertips with New, Versatile 12MP Diagnostic Display
Barco, a global leader in visualisation technology, has released a new 12MP healthcare diagnostic display system for picture archiving and communication systems (PACS) and breast imaging. The Nio Fusi
February 08, 2021 11:10
Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the third quarter of fiscal year 2020 (period ended December 31, 2020). TAKEDA CHIEF FIN
25 per page50 per page75 per page100 per page